-
Mashup Score: 3mSMART - 2 year(s) ago
The Risk Adapted Approach to Management of Multiple Myeloma and Related DisordersOur mission is to present the state of the art approach to management of these plasma cells disorders including Myeloma, Amyloidosis, and Waldenstrom’s Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence.
Source: mSMARTCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0mSMART - 2 year(s) ago
The Risk Adapted Approach to Management of Multiple Myeloma and Related DisordersOur mission is to present the state of the art approach to management of these plasma cells disorders including Myeloma, Amyloidosis, and Waldenstrom’s Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence.
Source: mSMARTCategories: Hem/Oncs, Latest HeadlinesTweet-
Second or later relapse. @MayoMyeloma https://t.co/x9KJzoJyXJ https://t.co/JVSKYvBNlN
-
-
Mashup Score: 1mSMART - 2 year(s) ago
The Risk Adapted Approach to Management of Multiple Myeloma and Related DisordersOur mission is to present the state of the art approach to management of these plasma cells disorders including Myeloma, Amyloidosis, and Waldenstrom’s Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence.
Source: mSMARTCategories: Hem/Oncs, Latest HeadlinesTweet-
#ASCO23 attendees - check out for our current mSMART guidelines for myeloma. Updated for 2023. We have posted guidelines for management of CAR-T and teclistamab related toxicities as well. https://t.co/pwue1T042G
-
-
Mashup Score: 1mSMART - 2 year(s) ago
The Risk Adapted Approach to Management of Multiple Myeloma and Related DisordersOur mission is to present the state of the art approach to management of these plasma cells disorders including Myeloma, Amyloidosis, and Waldenstrom’s Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence.
Source: mSMARTCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @IMFnurseMyeloma: Induction therapy in #myeloma by @VincentRK Outlined in https://t.co/NlVOTy4JeZ, individualized per pt when consideri…
-
-
Mashup Score: 1Waldenstrom's Macroglobulinemia — mSMART - 2 year(s) ago
Patient ResourcesRelavant LiteratureTreatment GuidelinesVideosContent in this section developed with input from Dr. Stephen Ansell and other members of the Lymphoma Group
Source: mSMARTCategories: Hem/Oncs, Latest HeadlinesTweet-
How we treat Waldenstrom Macroglobulinemia. mSMART. #MedTwitter @MayoMyeloma @MayoCancerCare @Rfonsi1 @MyelomaDrKapoor @myelomaMD @MorieGertz https://t.co/XqpQO7Ry8z https://t.co/BB5qWKDgoO
-
-
Mashup Score: 15mSMART - 2 year(s) ago
The Risk Adapted Approach to Management of Multiple Myeloma and Related DisordersOur mission is to present the state of the art approach to management of these plasma cells disorders including Myeloma, Amyloidosis, and Waldenstrom’s Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence.
Source: mSMARTCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @VincentRK: Updated mSMART recommendations for treatment of myeloma posted on https://t.co/x9KJzoK6Nh #MedTwitter 1/ New for relapsed…
-
-
Mashup Score: 0mSMART - 2 year(s) ago
The Risk Adapted Approach to Management of Multiple Myeloma and Related DisordersOur mission is to present the state of the art approach to management of these plasma cells disorders including Myeloma, Amyloidosis, and Waldenstrom’s Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence.
Source: mSMARTCategories: Hem/Oncs, Latest HeadlinesTweet-
4/ For more updates visit https://t.co/x9KJzoK6Nh
-
Updated mSMART recommendations for treatment of myeloma posted on https://t.co/x9KJzoK6Nh #MedTwitter 1/ New for relapsed myeloma, clear recommendations based on type of Triple-Class refractory. We define 3 types. @Rfonsi1 @myelomaMD @MorieGertz https://t.co/X8WAYUNCQm
-
-
Mashup Score: 3mSMART - 2 year(s) ago
The Risk Adapted Approach to Management of Multiple Myeloma and Related DisordersOur mission is to present the state of the art approach to management of these plasma cells disorders including Myeloma, Amyloidosis, and Waldenstrom’s Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence.
Source: mSMARTCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @VincentRK: Chat GPT knew all about https://t.co/x9KJzoK6Nh but … 1/2 #MedTwitter #myeloma https://t.co/8wfyKNmHJ0
-
-
Mashup Score: 0mSMART - 2 year(s) ago
The Risk Adapted Approach to Management of Multiple Myeloma and Related DisordersOur mission is to present the state of the art approach to management of these plasma cells disorders including Myeloma, Amyloidosis, and Waldenstrom’s Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence.
Source: mSMARTCategories: Hem/Oncs, Latest HeadlinesTweet-
Chat GPT knew all about https://t.co/x9KJzoK6Nh but … 1/2 #MedTwitter #myeloma https://t.co/8wfyKNmHJ0
-
-
Mashup Score: 7mSMART - 2 year(s) ago
The Risk Adapted Approach to Management of Multiple Myeloma and Related DisordersOur mission is to present the state of the art approach to management of these plasma cells disorders including Myeloma, Amyloidosis, and Waldenstrom’s Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence.
Source: mSMARTCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @VincentRK: Ahead of #ASH22 here is the current risk stratification I follow for myeloma. https://t.co/9SVglZ1DrM #ASH22 @myelomaMD ht…
-
Visit https://t.co/x9KJzoJyXJ for more details and guidelines for management of myeloma and related plasma cell dispersed.